Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer

Gynecologic Oncology

Volumn 128, Issue 1, 2013, Pages 77-82

  Garg, Gunjal ^a   Gao, Feng ^a   Wright, Jason D ^a,b   Hagemann, Andrea R ^a   Mutch, David G ^a   Powell, Matthew A ^a  

^a MO   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Endometrial cancer; Peritoneal cytology; Prognostic significance; Risk factor

Indexed keywords

ADULT; AGED; ASCITES FLUID CYTOLOGY; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PERITONEUM; RISK FACTORS; SEER PROGRAM;

EID: 84871922686     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.09.026     Document Type: Conference Paper

References (21)

1. P.M. Tebeu, G.Y. Popowski, H.M. Verkooijen, J. Casals, F. Ludicke, and G. Zeciri Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy Br J Cancer 89 11 2003 2023 2026
2. T. Kasamatsu, T. Onda, N. Katsumata, M. Sawada, T. Yamada, and R. Tsunematsu Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus Br J Cancer 88 2 2003 245 250
3. O. Fadare, M.R. Mariappan, D. Hileeto, S. Wang, J.N. McAlpine, and D.L. Rimm Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer Mod Pathol 18 5 2005 673 680
4. H.S. Kim, and Y.S. Song International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer? J Gynecol Oncol 20 3 2009 135 136
5. Surveillance, Epidemiology and End Results (SEER) program (www.seer.cancer.gov) SEER*stat Database: Incidence-SEER 17 Regs Limited-use + Hurricane Katrina Impacted Louisiana cases, Nov 2008 Sub (1973-2006 varying) - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
6. M.F. Milosevic, A.J. Dembo, and G.M. Thomas The clinical significance of malignant peritoneal cytology in stage I endometrial carcinoma Int J Gynecol Cancer 2 5 1992 225 235
7. J.R. Lurain The significance of positive peritoneal cytology in endometrial cancer Gynecol Oncol 46 2 1992 143 144
8. N. Kadar, H.D. Homesley, and J.H. Malfetano Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease Gynecol Oncol 46 2 1992 145 149
9. N. Takeshima, H. Nishida, T. Tabata, Y. Hirai, and K. Hasumi Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators Gynecol Oncol 82 3 2001 470 473
10. O. Preyer, A. Obermair, E. Formann, W. Schmid, L.C. Perrin, and B.G. Ward The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer Gynecol Oncol 86 3 2002 269 273
11. M. Kashimura, K. Sugihara, N. Toki, Y. Matsuura, T. Kawagoe, and T. Kamura The significance of peritoneal cytology in uterine cervix and endometrial cancer Gynecol Oncol 67 3 1997 285 290
12. L.J. Havrilesky, J.M. Cragun, B. Calingaert, A. Alvarez Secord, F.A. Valea, and D.L. Clarke-Pearson The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer Gynecol Oncol 104 2 2007 401 405
13. A.W. Kennedy, G.L. Peterson, S.N. Becker, C. Nunez, and K.D. Webster Experience with pelvic washings in stage I and II endometrial carcinoma Gynecol Oncol 28 1 1987 50 60
14. R.N. Grimshaw, W.C. Tupper, R.C. Fraser, M.G. Tompkins, and J.F. Jeffrey Prognostic value of peritoneal cytology in endometrial carcinoma Gynecol Oncol 36 1 1990 97 100
15. R. Yazigi, M.S. Piver, and L. Blumenson Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer Obstet Gynecol 62 3 1983 359 362
16. J.R. Lurain, N.K. Rumsey, J.C. Schink, C.B. Wallemark, and J.S. Chmiel Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium Obstet Gynecol 74 2 1989 175 179
17. D.A. Turner, D.M. Gershenson, N. Atkinson, N. Sneige, and A.T. Wharton The prognostic significance of peritoneal cytology for stage I endometrial cancer Obstet Gynecol 74 5 1989 775 780
18. Y. Saga, M. Imai, T. Jobo, H. Kuramoto, K. Takahashi, and R. Konno Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol 103 1 2006 277 280
19. V.R. Harouny, G.P. Sutton, S.A. Clark, H.E. Geisler, F.B. Stehman, and C.E. Ehrlich The importance of peritoneal cytology in endometrial carcinoma Obstet Gynecol 72 3 Pt 1 1988 394 398
20. S. Bansal, A.M. Buck, T.J. Herzog, I. Deutsch, W.M. Burke, and J.D. Wright Stage IIIA endometrial carcinoma: outcome and predictors of survival Obstet Gynecol 114 1 2009 100 105
21. C.M. Lee, B.M. Slomovitz, M. Greer, S. Sharma, M.A. Gregurich, and T. Burke Practice patterns of SGO members for stage IIIA endometrial cancer Gynecol Oncol 98 1 2005 77 83